Pyridinamide derivative as kinase inhibitors

Details for Australian Patent Application No. 2005219496 (hide)

Owner Merck Patent GmbH

Inventors Sirrenberg, Christian; Burgdorf, Lars Thore; Stieber, Frank; Buchstaller, Hans-Peter; Greiner, Hartmut; Grell, Matthias; Zenke, Frank; Amendt, Christiane

Agent Davies Collison Cave

Pub. Number AU-A-2005219496

PCT Pub. Number WO2005/085202

Priority 10 2004 009 238.9 26.02.04 DE

Filing date 13 January 2005

Wipo publication date 15 September 2005

International Classifications

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/085202 Priority application(s): WO2005/085202

18 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005219499-Use of thiadiazole urea derivatives

2005219492-A method of preventing or reducing temperature gradient caused bending of a structural element